Pharmacokinetics and Safety Assessment of VX-121/Tezacaftor/Deutivacaftor in Participants With Moderate Hepatic Impairment
Clinical trial NCT05437120 · COMPLETED
Trial details
- NCT number
- NCT05437120
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-22
- Primary completion
- 2023-03-16
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.